March 14, 2016 / 2:48 PM / a year ago

BUZZ-Valeant shares slide ahead of long-awaited earnings report

1 Min Read

** U.S.-listed shares of Valeant Pharmaceuticals down 3.6 pct in Monday morning trading, ahead of expected Q4 earnings report on Tuesday

** Valeant shares worst daily perfomer in NYSE Arca Pharmaceutical index, which is off 0.7 pct

** Drugmaker is under pressure to introduce more transparency into operations, expand management ranks to regain credibility in the investment community, Reuters reported on Friday

** Shares have lost about three quarters of value from 52-week high of $263.81 reached in August, as it faced growing scrutiny over drug pricing and its connection to a specialty pharmacy

** YTD, Valeant shares are off 34 pct vs 6.5 pct decline for NYSE Arca pharma index

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below